Your browser doesn't support javascript.
loading
Evolution of Imipenem-Relebactam Resistance Following Treatment of Multidrug-Resistant Pseudomonas aeruginosa Pneumonia.
Shields, Ryan K; Stellfox, Madison E; Kline, Ellen G; Samanta, Palash; Van Tyne, Daria.
Afiliação
  • Shields RK; Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
  • Stellfox ME; XDR Pathogen Laboratory, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
  • Kline EG; Antibiotic Management Program, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
  • Samanta P; Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
  • Van Tyne D; Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Clin Infect Dis ; 75(4): 710-714, 2022 09 10.
Article em En | MEDLINE | ID: mdl-35136967
ABSTRACT
We report the emergence of imipenem-relebactam nonsusceptible Pseudomonas aeruginosa in 5 patients treated for nosocomial pneumonia for 10-28 days. Genome sequence analysis identified treatment-emergent mutations in MexAB-OprM and/or MexEF-OprN efflux operons that arose independently in each patient across distinct P. aeruginosa sequence types. Testing with efflux-inhibitor PAßN restored imipenem-relebactam susceptibility.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pneumonia / Pseudomonas aeruginosa Limite: Humans Idioma: En Revista: Clin Infect Dis Assunto da revista: DOENCAS TRANSMISSIVEIS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pneumonia / Pseudomonas aeruginosa Limite: Humans Idioma: En Revista: Clin Infect Dis Assunto da revista: DOENCAS TRANSMISSIVEIS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos